Startseite
Impressum
Datenschutz
 
 
  SPOT ON
 

The 800 million dollar myth … What does drug development actually cost?

 
  NEW ON THE MARKET
 

Oral immunosuppressant fingolimod (GILENYA) for multiple sclerosis

 
  THERAPY FROM A CRITICAL VIEWPOINT
 

Bevacizumab: alternative to ranibizumab for macular degeneration

 
  a-t READER'S QUESTIONS AND COMMENTS
 

Costs of coagulation self-testing

 
  IN BRIEF
 

´Gastroenterology´ retracts study on pancreatitis with exenatide (BYETTA) and sitagliptin (JANUVIA, XELEVIA)

 
  CURRENT ADR NETWORK REPORT

Agranulocytosis and anaphylaxis due to metamizol (NOVALGIN, generics)

 
  SIDE EFFECTS
 

Update: progressive leukencephalopathy with natalizumab (TYSABRI)

New data on thromboembolism due to oral contraceptives containing drospirenone

 
  e a-t IN THE INTERNET
 

Great Britain: no routine pneumococcal vaccination of elderly

Confirmed: Swine flu vaccine (PANDEMRIX) and narcolepsy

 
© arznei-telegramm 5/2011